The Metabolic Blend is strictly for laboratory research and is commonly employed in the following investigational areas:

Metabolic Homeostasis and Obesity

Research models utilize this blend to evaluate the synergistic regulation of adipose tissue and lipid metabolism. Investigations focus on quantifying how MOTS-c promotes metabolic homeostasis and reduces obesity/insulin resistance, while NNMT inhibition via 5-Amino-1MQ prevents the drainage of NAD+ precursors, driving a systemic shift toward increased energy expenditure.

Cellular Bioenergetics and Mitochondrial Dysfunction

Experimental protocols employ this combination to characterize intracellular energy states. Studies assess mitochondrial efficiency, oxidative phosphorylation, and the molecular stress response, observing how MOTS-c translocates to the nucleus during metabolic stress to regulate adaptive gene expression.

Neuroprotection and Cognitive Health

In models of neuroinflammation and cognitive decline, researchers utilize NAD+-boosting compounds to study their restorative effects. Assays measure the activation of Sirt1/PGC-1α signaling pathways to determine the capacity of the blend to improve cognition and maintain neural cell viability.

Oncology and Epigenetic Regulation

This blend is used in specialized oncology research to determine the effects of NNMT inhibition on tumor cell metabolism. By combining 5-Amino-1MQ with NAD+ and MOTS-c, investigators explore how altering the cellular methylation potential and NAD+ availability influences the “Warburg effect” and broader epigenetic cancer progression.

Pathway / Mechanistic Context

The primary mechanistic context for this blend involves a multi-targeted, systems-level approach to energy restoration and metabolic signaling.

• NNMT Inhibition: 5-Amino-1MQ competitively blocks the transfer of a methyl group from SAM to nicotinamide, preserving the nicotinamide pool for the NAD+ salvage pathway and preventing the depletion of universal methyl donors.
• Mitochondrial-Nuclear Signaling: MOTS-c activates AMP-activated protein kinase (AMPK) and translocates to the nucleus in response to metabolic stress, directly interacting with transcription factors to regulate glucose and lipid metabolism.
• NAD+ Salvage and Sirtuin Activation: Direct supplementation of NAD+ combined with the salvage pathway preservation from 5-Amino-1MQ drives the robust activation of NAD+-dependent enzymes (such as Sirtuins and PARPs), promoting DNA repair, mitochondrial biogenesis, and cellular longevity.

Preclinical Research Summary

Published preclinical literature documents investigations of the components within this blend across multiple experimental models:

• In diet-induced obesity and diabetes models, MOTS-c was shown to strongly promote metabolic homeostasis, regulate adipose function, and reduce insulin resistance.
• Research indicates that NNMT inhibition using 5-Amino-1MQ limits adipocyte lipogenesis and reduces the risk of obesity and diabetes by shunting precursors back into the NAD+ salvage pathway.
• Studies on neuroinflammation demonstrate that NAD+ supplementation improves cognitive endpoints by activating the Sirt1/PGC-1α axis, mitigating cellular stress.
• Mechanistic investigations reveal that MOTS-c rapidly translocates to the nucleus during metabolic stress to orchestrate cellular adaptive responses, confirming its role as an exercise mimetic.

Form & Analytical Testing

• Solid-Phase Peptide Synthesis & Chemical Synthesis
• Lyophilization
• Identity Verification: Mass Spectrometry (MS) to confirm the molecular weight and identity of the peptide, coenzyme, and small molecule components.
• Purity Verification: High-Performance Liquid Chromatography (HPLC) is performed to ensure the product meets the purity standard required for reproducible research.

Referenced Citations

References are provided for informational purposes only and are not clinical claims.

• Rajman L, et al. (2018). Therapeutic potential of NAD-boosting molecules in vivo. Cell Metab. https://doi.org/10.1016/j.cmet.2018.02.011
• Okabe K, et al. (2019). Altered NAD+ metabolism in metabolic disorders. J Biomed Sci. https://doi.org/10.1186/s12929-019-0527-8
• Zhao Y, et al. (2021). NAD+ improves cognition via Sirt1/PGC-1α. J Neuroinflammation. https://doi.org/10.1186/s12974-021-02250-8
• Kim K, et al. (2018). MOTS-c translocates to the nucleus during metabolic stress. Cell Metab. https://doi.org/10.1016/j.cmet.2018.06.008
• Lu H, et al. (2019). MOTS-c regulates adipose homeostasis and prevents metabolic dysfunction. J Mol Med. https://doi.org/10.1007/s00109-018-01738-w
• Lee C, et al. (2015). MOTS-c promotes metabolic homeostasis and reduces obesity/insulin resistance. Cell Metab. https://doi.org/10.1016/j.cmet.2015.02.009
• Conlon N, Ford D. (2022). Systems approach to NAD+ restoration via NNMT inhibition. Biochem Pharmacol. https://doi.org/10.1016/j.bcp.2022.114946
• Liu J, et al. (2021). NNMT inhibition reduces obesity and diabetes risk. Biomed Res Int. https://doi.org/10.1155/2021/9924314
• Li X, et al. (2022). NNMT as a biomarker and target in cancer. Front Oncol. https://doi.org/10.3389/fonc.2022.894744

• Stable at room temperature for up to 90 days. For long-term storage, keep at -20°C (-4°F) or colder.
• Once mixed with a solvent (e.g., bacteriostatic water), the solution must be stored at 4 °C (39°F) and utilized within 30 days. Avoid repeated freeze-thaw cycles, as this degrades the peptide structure.

RESEARCH USE ONLY

This product is intended strictly for laboratory research use only. It is not for human or veterinary use. It is not intended for diagnosis, treatment, cure, or prevention of any disease. All purchases are subject to our Terms of Service and Purity Guarantee.

No COAs available for this product.